Day 3 serum inhibin-B levels as predictors of outcome in GnRH agonist treated IVF-ET cycles.

被引：0
|
作者：
Hughes, D [1 ]
Attia, G [1 ]
Smith, D [1 ]
Carr, BR [1 ]
Byrd, W [1 ]
机构：
[1] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
FERTILITY AND STERILITY | 2001年 / 76卷 / 03期
关键词：
D O I：
10.1016/S0015-0282(01)02348-2
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P22
引用
收藏
页码：S118 / S119
页数：2
相关论文
共 50 条
  • [31] COMPARISON OF HORMONAL LEVELS IN POLYCYSTIC OVARY PATIENTS USING SHORT AND LONG ANTAGONIST PROTOCOLS DURING CONTROLLED OVARIAN STIMULATION IN IVF-ET CYCLES.
    Thakur, M.
    Bolnick, A.
    Abuzeid, O.
    Raju, R.
    Dai, J.
    Puscheck, E. E.
    Diamond, M. P.
    Abuzeid, M. I.
    FERTILITY AND STERILITY, 2015, 104 (03) : E320 - E320
  • [32] Does double trigger (GnRH-agonist plus hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study
    Haas, Jigal
    Zilberberg, Eran
    Nahum, Ravit
    Sason, Aya Mor
    Hourvitz, Ariel
    Gat, Itai
    Orvieto, Raoul
    GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (07) : 628 - 630
  • [33] The outcome of different dose GnRH agonist suppression on in vitro fertilization-embryo transfer (IVF-ET) cycle outcome in patients with stage III/IV endometriosis.
    Ma, C.
    Qiao, J.
    Liu, P.
    Chen, G.
    FERTILITY AND STERILITY, 2007, 88 : S294 - S295
  • [34] GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study
    Papanikolaou, E. G.
    Pados, G.
    Grimbizis, G.
    Bili, E.
    Kyriazi, L.
    Polyzos, N. P.
    Humaidan, P.
    Tournaye, H.
    Tarlatzis, B.
    HUMAN REPRODUCTION, 2012, 27 (06) : 1822 - 1828
  • [35] Pregnant and non-pregnant IVF-ET cycles yield adequate endometrial development regardless of serum estradiol levels.
    Dean, M. E.
    Frankfurter, D.
    Dayal, M.
    Dubey, A. K.
    Peak, D.
    Gindoff, P. R.
    FERTILITY AND STERILITY, 2007, 88 : S294 - S294
  • [36] Impact of the use of recombinant LH (rLH) versus urinary LH (uLH) in conjunction with recombinant FSH (rFSH) in GnRH agonist and antagonist-treated IVF cycles.
    Duran, H.
    Tambucho, P.
    Bocca, S.
    Stadtmauer, L.
    Oehninger, S.
    FERTILITY AND STERILITY, 2006, 86 : S423 - S423
  • [37] Progesterone rise on the day of HCG administration impairs the pregnancy outcome in day 3 single embryo transfer, while has no effect on day 5 single blastocyst transfer during GnRH-antagonist stimulated IVF cycles.
    Papanikolaou, EG
    Kolibianakis, E
    Pozzobon, C
    Tank, P
    Tournaye, H
    Devroey, P
    FERTILITY AND STERILITY, 2005, 84 : S148 - S148
  • [38] Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study
    Ioannidis, G
    Sacks, G
    Reddy, N
    Seyani, L
    Margara, R
    Lavery, S
    Trew, G
    HUMAN REPRODUCTION, 2005, 20 (03) : 741 - 746
  • [39] MID-LUTEAL SERUM PROGESTERONE AS A PREDICTOR OF PREGNANCY IN IVF-ET CYCLES: MAY INCREASING THE DOSAGE OF PROGESTERONE SUPPLEMENTATION WOULD IMPROVE THE OUTCOME?
    Ellenbogen, A.
    Yaakobi, D.
    Fainaru, O.
    Shavit, T.
    Aslish, N.
    FERTILITY AND STERILITY, 2013, 100 (03) : S299 - S300
  • [40] Effect of elevated estradiol levels on the hCG administration day on IVF pregnancy and birth outcomes in the long GnRH-agonist protocol: analysis of 3393 cycles
    Wang, Meimei
    Hao, Cuifang
    Bao, Hongchu
    Huang, Xin
    Liu, Zhenteng
    Zhang, Wei
    Li, Fenghua
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (02) : 407 - 414
12345